Your account is not claimed yet. You can sign up with ORCID to claim your account.

Michael S Khodadoust (Michael Khodadoust)

ORCID

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Venues

Blood

JCO precision oncology

Oncoimmunology

Blood advances

This page only lists publications with an associated author ORCID identifier.

Publications

Michael S Khodadoust, Oscar Silva
Hepatosplenic T-cell lymphoma with STAT5B and SETD2 mutations recurring as cells with NK-cell immunophenotype. Blood 141 (5) (2023)
Tanaya Shree, Sarah Elena Haebe, Debra K Czerwinski, Erik Eckhert, Grady Day, Anuja Sathe, Susan M Grimes, Matthew J Frank, Lauren Maeda, Ash A Alizadeh, Ranjana H Advani, Richard T Hoppe, Steven R Long, Brock A Martin, Michael G Ozawa, Michael S Khodadoust, Hanlee P Ji, Ronald Levy
A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single cell analysis. Blood advances (2023)
Michael S Khodadoust, Oscar Silva
Hepatosplenic T-cell lymphoma with STAT5B and SETD2 mutations recurring as cells with NK-cell immunophenotype. Blood 141 (5) (2023)
Joseph G Schroers-Martin, Joanne Soo, Gabriel Brisou, Florian Scherer, David M Kurtz, Brian J Sworder, Michael S Khodadoust, Michael C Jin, Agnès Bru, Chih Long Liu, Henning Stehr, Paolo Vineis, Yasodha Natkunam, Lauren R Teras, Joo Y Song, Bertrand Nadel, Maximillian Diehn, Sandrine Roulland, Ash A Alizadeh
Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors. Cancer discovery (2023)
Michael S Khodadoust, Oscar Silva
Hepatosplenic T-cell lymphoma with STAT5B and SETD2 mutations recurring as cells with NK-cell immunophenotype. Blood 141 (5) (2023)
Michael S Khodadoust, Eric Mou, Youn H Kim
Integrating Novel Agents into the Treatment of Advanced Mycosis Fungoides and Sézary Syndrome. Blood (2022)
Tianying Su, George E Duran, Alexa C Kwang, Nirasha Ramchurren, Steven P Fling, Youn H Kim, Michael S Khodadoust
Single-cell RNA-sequencing reveals predictive features of response to pembrolizumab in Sézary syndrome. Oncoimmunology 11 (1) (2022)
Sara Beygi, George E Duran, Sebastian Fernandez-Pol, Alain H Rook, Youn H Kim, Michael S Khodadoust
Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma. Blood 139 (26) (2022)
Sebastian Fernandez-Pol, Nastaran Neishaboori, Courtney M Chapman, Michael S Khodadoust, Youn H Kim, Kerri E Rieger, Carlos J Suarez
Two Cases of Mycosis Fungoides With PCM1-JAK2 Fusion. JCO precision oncology 5 (2022)
Katie Lee, Mark G Evans, Lei Yang, Spencer Ng, Caroline Snowden, Michael S Khodadoust, Ryanne A Brown, Nicholas A Trum, Christiane Querfeld, Linda T Doan, Jinming Song, Hailing Zhang, Alejandro A Gru, Gary S Wood, David A Wada, Vignesh Shanmugam, Paul L Haun, Jon C Aster, Lyn M Duncan, Joan Guitart, David M Weinstock, Valentina Nardi, Jaehyuk Choi
Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway. Blood 138 (23) (2022)
Tanaya Shree, Vishnu Shankar, Julian J K Lohmeyer, Debra K Czerwinski, Joseph G Schroers-Martin, Gladys M Rodriguez, Sara Beygi, Alyssa M Kanegai, Karen S Corbelli, Etelka Gabriel, David M Kurtz, Michael S Khodadoust, Neel K Gupta, Lauren S Maeda, Ranjana H Advani, Ash A Alizadeh, Ronald Levy
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity. Blood cancer discovery 3 (2) (2022)

Michael S Khodadoust.css-eqlu8i{font-size:small;padding-left:4px;} (Michael Khodadoust)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael S Khodadoust (Michael Khodadoust)